These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12562331)

  • 1. Recognition of bovine respiratory syncytial virus proteins by bovine CD8+ T lymphocytes.
    Gaddum RM; Cook RS; Furze JM; Ellis SA; Taylor G
    Immunology; 2003 Feb; 108(2):220-9. PubMed ID: 12562331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions.
    Taylor G; Thomas LH; Furze JM; Cook RS; Wyld SG; Lerch R; Hardy R; Wertz GW
    J Gen Virol; 1997 Dec; 78 ( Pt 12)():3195-206. PubMed ID: 9400970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of antiviral CD8 T cell responses during primary and post-vaccination secondary bovine respiratory syncytial virus infection.
    Antonis AF; Claassen EA; Hensen EJ; de Groot RJ; de Groot-Mijnes JD; Schrijver RS; van der Most RG
    Vaccine; 2006 Mar; 24(10):1551-61. PubMed ID: 16310293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of CD4+ T cell epitopes on the fusion (F) and attachment (G) proteins of bovine respiratory syncytial virus (BRSV).
    Fogg MH; Parsons KR; Thomas LH; Taylor G
    Vaccine; 2001 Apr; 19(23-24):3226-40. PubMed ID: 11312019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine.
    Buchholz UJ; Granzow H; Schuldt K; Whitehead SS; Murphy BR; Collins PL
    J Virol; 2000 Feb; 74(3):1187-99. PubMed ID: 10627529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
    Antonis AF; van der Most RG; Suezer Y; Stockhofe-Zurwieden N; Daus F; Sutter G; Schrijver RS
    Vaccine; 2007 Jun; 25(25):4818-27. PubMed ID: 17499893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpesvirus-1 expressing the attachment glycoprotein of BRSV.
    Taylor G; Rijsewijk FA; Thomas LH; Wyld SG; Gaddum RM; Cook RS; Morrison WI; Hensen E; van Oirschot JT; Keil G
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1759-67. PubMed ID: 9680140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine model of respiratory syncytial virus infection.
    Taylor G
    Curr Top Microbiol Immunol; 2013; 372():327-45. PubMed ID: 24362697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses against epitopes on the F protein of bovine respiratory syncytial virus differ in infected or vaccinated cattle.
    Schrijver RS; Hensen EJ; Langedijk JP; Daus F; Middel WG; Kramps JA; van Oirschot JT
    Arch Virol; 1997; 142(11):2195-210. PubMed ID: 9672586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology of bovine respiratory syncytial virus in calves.
    Guzman E; Taylor G
    Mol Immunol; 2015 Jul; 66(1):48-56. PubMed ID: 25553595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T lymphocyte activity and cytokine expression in calves vaccinated with formalin-inactivated bovine respiratory syncytial virus prior to challenge.
    Woolums AR; Gunther RA; McArthur-Vaughan K; Anderson ML; Omlor A; Boyle GA; Friebertshauser KE; McInturff PS; Gershwin LJ
    Comp Immunol Microbiol Infect Dis; 2004 Jan; 27(1):57-74. PubMed ID: 14656542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a DRB3*011:01-restricted CD4
    Kaplan BS; Hofstetter AR; McGill JL; Lippolis JD; Norimine J; Dassanayake RP; Sacco RE
    Front Immunol; 2023; 14():1040075. PubMed ID: 36891302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine responses of bovine dendritic cells and T cells following exposure to live or inactivated bovine respiratory syncytial virus.
    Werling D; Collins RA; Taylor G; Howard CJ
    J Leukoc Biol; 2002 Aug; 72(2):297-304. PubMed ID: 12149420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming of multiple T cell subsets by modified-live and inactivated bovine respiratory syncytial virus vaccines.
    Sandbulte MR; Roth JA
    Vet Immunol Immunopathol; 2003 Oct; 95(3-4):123-33. PubMed ID: 12963273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection.
    Schlender J; Zimmer G; Herrler G; Conzelmann KK
    J Virol; 2003 Apr; 77(8):4609-16. PubMed ID: 12663767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunobiology of bovine respiratory syncytial virus infections].
    Schrijver RS
    Tijdschr Diergeneeskd; 1998 Nov; 123(22):658-62. PubMed ID: 9836385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic analysis of local cellular responses in calves infected with bovine respiratory syncytial virus.
    Mcinnes E; Sopp P; Howard CJ; Taylor G
    Immunology; 1999 Mar; 96(3):396-403. PubMed ID: 10419349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell populations responsive to bovine respiratory syncytial virus in seronegative calves.
    Sandbulte MR; Roth JA
    Vet Immunol Immunopathol; 2002 Jan; 84(1-2):111-23. PubMed ID: 11825602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation with CpG oligodeoxynucleotides increases cellular immunity and protection induced by vaccination of calves with formalin-inactivated bovine respiratory syncytial virus.
    Mapletoft JW; Oumouna M; Townsend HG; Gomis S; Babiuk LA; van Drunen Littel-van den Hurk S
    Virology; 2006 Sep; 353(2):316-23. PubMed ID: 16828832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease.
    Spender LC; Hussell T; Openshaw PJ
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1751-8. PubMed ID: 9680139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.